Your browser version is outdated. We recommend that you update your browser to the latest version.

Board of Directors


Chairman of the Board: Peter Birk, PhD

Dr. Birk is an experienced business accelerator and investor and part of the Accelerace Management team. Dr Birk has a background from management positions in the biotech industry as VP in EpiTherapeutics and Pharmexa, and CSO in ACE BioSciences. Dr Birk has a strong experience in the field of vaccines and immunotherapy, enabling him to strengthen MonTa Biosciences in both business and R&D. See more about Dr Birk here.



BoD member: Esper Boel, PhD, CSO at Paratech A/S

Dr. Boel is former CVP and head of Biotechnology at Novo Nordisk A/S and former CSO of Discovery at Symphogen A/S. He was centrally involved in building the inflammation and oncology portfolio at Novo Nordisk A/S from 2002 to 2013. Dr. Boel has held key strategic, consulting and advisory positions in several biotech companies with a focus on immunotherapy, making Dr. Boel a well-respected expert in R&D, business development and strategic aspects. See more about Dr Boel here.


BoD Member: Lone Schøtt Kunøe, CEO Consolidated Biosciences 


BoD Member:  Sven Madsen, CFO Consolidated Holdings